期刊
CURRENT DIABETES REVIEWS
卷 18, 期 6, 页码 -出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1573399817666210503140303
关键词
Anti-granulocyte SPECT/CT; diabetic foot; osteomyelitis; clinical benefit; magnetic resonance imaging; comparisons
This study evaluated the clinical value of 99mTc-antigranulocyte SPECT/CT in DFO patients and found that it did not change the clinical approach.
Background: Magnetic resonance imaging (MRI) is the actual gold standard for the radiological diagnosis of diabetic foot osteomyelitis (DFO). Materials and Methods: MRI is not always available and many patients have contraindications. We evaluated the clinical value of 99mTc-antigranulocyte SPECT/CT (AGS) in eight DFO patients who underwent MRI before. Results: The goal was to have a better clinical view on the extent of bone infection and to ameliorate the surgical approach for DFO. However, this additional scintigraphy did not change anything in the clinical approach. Conclusion: We shared our experience with AGS for clinical management of complex DFO cases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据